Related Experiment Video
Updated: Feb 16, 2026

07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.4K
Avelumab demonstrates promise in advanced NSCLC
Ariel E Marciscano1, James L Gulley1
1James L. Gulley: Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Oncotarget
|December 22, 2017
Summary
No abstract available in PubMed .
Keywords:
anti-PD-L1antibody-dependent cell-mediated cytotoxicityavelumabimmune checkpoint inhibitornon-small cell lung cancerMore Related Videos
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
11.1K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
11.1K